SummaryThe purpose of the feasibility study is to test the new patient-led follow-up method for low risk head and neck cancer patients in a small number of patients before testing in a larger clinical study.
Number of participants30 patients and their recruiting clinicians.
- Head and neck cancer patients, at around 1 year after finishing treatment
- Aged 18 years or older
- Written informed consent by the patients.
Feasibility Study Overview
|Chief Investigator:||Dr Paul Nankivell|
|Open to new sites?||Yes|
|First SIV:||17th January 2022|
|First patient recruited:||20th May 2022|
|Anticipated recruitment end date:||August 2022|
More information for healthcare professionals - please click here